Business Context and Reporting Period
This Form 8-K is filed by Onconova Therapeutics, Inc. (ONTX) on May 21, 2019. The report addresses a notification received from the Nasdaq Stock Market regarding the company's compliance with continued listing standards. Note: The request metadata lists "Traws Pharma, Inc.", but the filing text explicitly identifies the registrant as Onconova Therapeutics, Inc.
Key Financial Metrics
The filing references financial data from the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2019.
- Stockholders' Equity: Approximately $1.5 million deficit.
- Nasdaq Minimum Requirement: $2.5 million stockholders' equity.
- Compliance Status: The company does not meet the minimum stockholders' equity requirement, nor does it meet alternative standards for market value of listed securities or net income from continuing operations.
The filing text does not provide specific values for revenue, profit, cash flow, margins, or debt.
Material Changes and Listing Status
On May 20, 2019, Nasdaq notified the Company that it is no longer in compliance with Nasdaq Listing Rule 5550(b)(1) due to the stockholders' deficit. This notification has no immediate effect on the listing of the Company's securities.
Outlook, Risks, and Contingencies
Compliance Timeline:
- Plan Submission Deadline: The Company has 45 calendar days (until July 5, 2019) to submit a plan to regain compliance.
- Extension Possibility: If the plan is accepted, Nasdaq may grant an extension until November 18, 2019, to regain compliance.
- Delisting Risk: If the plan is not accepted, the extension is not granted, or compliance is not achieved by the deadlines, Nasdaq could provide notice of delisting.
- Hearing Option: In the event of a delisting notice, the Company may request a hearing before an independent Hearings Panel, which could grant an additional extension of up to 180 calendar days.
Management Commentary: The Company is evaluating various courses of action to regain compliance and intends to timely submit a plan. However, there is no assurance that the plan will be accepted or that the Company will successfully maintain its listing.
Investor Verification Checklist
- Verify the current stockholders' equity position in the most recent 10-Q or 10-K filings.
- Monitor the submission of the compliance plan to Nasdaq by the July 5, 2019 deadline.
- Review any subsequent announcements regarding the acceptance of the compliance plan or potential delisting notices.
- Assess the Company's liquidity and capital raise strategies to address the equity deficit.